あすか製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証1部 | 医薬品 | 4514/E00929 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2020/02/28 | 日証協 | 268,487株 | +5.73% | 139,353株 | -0.15% | 222,111株 | +18.25% | 60,362株 | +60.81% |
2020/02/21 | 日証協 | 253,934株 | +12.45% | 139,568株 | -11.74% | 187,834株 | +7.68% | 37,536株 | -24.82% |
2020/02/14 | 日証協 | 225,825株 | +9.77% | 158,127株 | +35.03% | 174,434株 | -2.66% | 49,927株 | +42.75% |
2020/02/07 | 日証協 | 205,733株 | -11.46% | 117,103株 | +10.11% | 179,208株 | +0.27% | 34,974株 | +34.69% |
2020/01/31 | 日証協 | 232,352株 | +3.19% | 106,348株 | -7.52% | 178,734株 | +11.2% | 25,966株 | +11.44% |
2020/01/24 | 日証協 | 225,168株 | -43.68% | 115,000株 | +16.83% | 160,733株 | -52.29% | 23,300株 | +39.52% |
2020/01/17 | 日証協 | 399,831株 | -4.84% | 98,435株 | +4.01% | 336,878株 | +0.81% | 16,700株 | -65% |
2020/01/10 | 日証協 | 420,150株 | +5% | 94,636株 | +255.77% | 334,178株 | +11.18% | 47,717株 | +341.82% |
2019/12/30 | 日証協 | 400,133株 | -2.58% | 26,600株 | -58.01% | 300,587株 | -1.8% | 10,800株 | -94.33% |
2019/12/27 | 日証協 | 410,750株 | -0.27% | 63,342株 | -13.7% | 306,087株 | +92.29% | 190,624株 | +425.99% |
2019/12/20 | 日証協 | 411,850株 | +2.89% | 73,394株 | +78.01% | 159,180株 | +5.96% | 36,241株 | -29.49% |
2019/12/13 | 日証協 | 400,293株 | +0.06% | 41,230株 | +143.98% | 150,227株 | +34.1% | 51,402株 | +337.58% |
2019/12/06 | 日証協 | 400,039株 | -4.43% | 16,899株 | -68.55% | 112,025株 | -8.43% | 11,747株 | -66.05% |
2019/11/29 | 日証協 | 418,590株 | +2.5% | 53,727株 | +301.13% | 122,340株 | -42.8% | 34,601株 | -70.47% |
2019/11/22 | 日証協 | 408,364株 | -6.85% | 13,394株 | -10.03% | 213,884株 | +26.47% | 117,161株 | +260.36% |
2019/11/15 | 日証協 | 438,376株 | +3.7% | 14,887株 | -54.81% | 169,120株 | +5.98% | 32,512株 | -46.23% |
2019/11/08 | 日証協 | 422,719株 | +0.51% | 32,943株 | -4.79% | 159,584株 | -7.05% | 60,470株 | +164.27% |
2019/11/01 | 日証協 | 420,586株 | +2.07% | 34,600株 | -66.27% | 171,684株 | -11.95% | 22,882株 | -26.64% |
2019/10/25 | 日証協 | 412,075株 | +9.28% | 102,582株 | +186.47% | 194,975株 | -3.09% | 31,191株 | +9.35% |
※株式分割は考慮していませんのでご注意ください。
Page Top